Suzhou, Jiangsu
China
20
2024-01-18
16
2019-11-26
These are the the leading inventors for applications assigned to CRYSTAL PHARMATECH CO., LTD.:
CRYSTAL PHARMATECH CO., LTD. based in Suzhou, Jiangsu, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
NEW CRYSTAL FORM OF P-TOLUENESULFONATE SALT OF DIAZABICYCLIC COMPOUND AND PREPARATION METHOD THEREFOR
#2 | 2023-12-28CRYSTALLINE FORMS OF QUINAZOLINONE COMPOUND AND PROCESS FOR PREPARING THE SAME
#3 | 2023-06-29CRYSTALLINE FORMS OF A SULFONAMIDE COMPOUND AND PROCESSES FOR PREPARING THE SAME
#4 | 2019-11-14 ✅ Patent 10,487,064 granted on 2019-11-26Crystalline forms of selective S1P1 receptor modulator and preparation method thereof
#5 | 2019-07-18 ✅ Patent 10,562,855 granted on 2020-02-18Crystalline form of lenvantinib mesylate and process of preparation thereof
#6 | 2019-04-04HYDROCHLORIDE SALT CRYSTAL OF DRUG FOR TREATING OR PREVENTING JAK-ASSOCIATED DISEASE AND PREPARATION METHOD THEREOF
#7 | 2018-12-13 ✅ Patent 10,442,775 granted on 2019-10-15Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium salt
#8 | 2018-09-20 ✅ Patent 10,246,437 granted on 2019-04-02Crystal form of neratinib maleate and preparation method therefor
#9 | 2018-08-16 ✅ Patent 10,308,641 granted on 2019-06-04Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof
#10 | 2018-06-21 ✅ Patent 10,273,262 granted on 2019-04-30Crystalline form A of obeticholic acid and preparation method thereof
#11 | 2018-06-21 ✅ Patent 10,266,523 granted on 2019-04-23Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
#12 | 2018-06-07 ✅ Patent 10,246,418 granted on 2019-04-02Crystal form of lenvatinib methanesulfonate salt and preparation method thereof
#13 | 2018-03-29 ✅ Patent 10,233,144 granted on 2019-03-19Crystalline form of AHU377, preparation method and use thereof
#14 | 2018-03-15 ✅ Patent 10,196,395 granted on 2019-02-05Crystalline form alpha of IPI-145 and preparation method thereof
#15 | 2018-03-08 ✅ Patent 10,138,239 granted on 2018-11-27Preparation method of crystalline form a of PCI-32765
#16 | 2018-03-01 ✅ Patent 10,323,035 granted on 2019-06-18Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereof
#17 | 2018-02-15 ✅ Patent 10,377,757 granted on 2019-08-13Crystal form of JAK inhibitor and preparation method thereof
#18 | 2017-12-21 ✅ Patent 9,957,240 granted on 2018-05-01Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
#19 | 2016-12-01 ✅ Patent 9,969,701 granted on 2018-05-15Salts and co-crystals of lesinurad
#20 | 2016-10-13 ✅ Patent 10,351,536 granted on 2019-07-16Crystalline forms of lesinurad and its sodium salt
Also check out CRYSTAL PHARMATECH CO., LTD's (Suzhou, Jiangsu, China) applicant profile with 19 patent applications submitted.
116163 ⎘